GLP-1 Receptor Agonists: The Truth Behind the Trend
Michael Blyumin, clinical pharmacist at Stanford Health Care reviews FDA-approved GLP-1 receptor agonists, including their dosing, administration, and benefits, such as significant blood sugar reduction, weight loss, and cardiovascular health improvements. He details the pathophysiology of diabetes, the function of GLP-1s in blood sugar regulation, and the mechanisms of GLP-1 receptor agonists. Learn the benefits and risks, practical considerations for these medications in diabetes management, and the impact of stopping these medications. View the powerpoint: https://l.ead.me/glp1 #Exenatide #Byetta #Bydureon #Lixisenatide #Adlyxin #Liraglutide #Victoza #Saxenda #Dulaglutide #Trulicity #Semaglutide #Ozempic #Rybelsus #Wegovy #Tirzepatide #Mounjaro #Zepbound Michael Blyumin, PharmD, CDCES, is an ambulatory care clinical pharmacist at Stanford Health Care primarily working in the primary care and endocrinology space. Michael completed his PharmD at UCSF School of Pharmacy and PGY1 pharmacy practice residency with an emphasis in ambulatory care at Stanford Health Care. He is a certified diabetes education and care specialist (CDCES) and serves as the Stanford Health Care ambulatory care pharmacy residency program coordinator. Outside of clinical practice, Michael is a clinical advisor for MedHug, Inc, seeking to improve patient outcomes by providing healthcare systems with transparency on medicare prescription coverage. This talk is part of the Diabetes Wellness Group Monthly Webinar from the Stanford Medicine Diabetes Care Program. Webinars are free and open to adults with diabetes and their families. Register for future webinars: http://l.ead.me/shl-events and learn about Stanford's Diabetes Care Program http://l.ead.me/shc-dcp Take 5 minutes for yourself. Check out Stanford Health Library's free mindfulness and meditation resources including guided meditations to help ease pain, aid in healthful sleep, promote successful surgery, and more: http://l.ead.me/shl-mindfulness

Webinar—The Golden Era of GLP-1 Drugs

Transfusion and Beyond: Understanding Supportive Care in MDS

When Your Diabetes Medication is the Latest Craze: Updates and Navigating Drug Shortages

I Made 7 GLP-1 Mistakes (So You Don't Have To)

150: Why Tirzepatide Works Better Than GLP-1 Alone

What your doctor should tell you before taking GLP-1s

A Neuroscientist Breaks Down GLP–1s, Genetics & the Real Science of Fat Loss | Zachary A. Knight

Serena Williams and Oprah on Deciding to Take GLP-1 Medications

Are We Using GLP-1 Medications All Wrong? with Dr. Ben Bikman

I’m a Pathologist: The "Biological Cost" of Ozempic and Mounjaro.

GLP-1s Are a Lot Weirder Than Anyone Thought | The Ezra Klein Show

Fluid Management in the Hospital: Controversies and Consensus

10 Best Foods That Make Ozempic & Zepbound Work BETTER: Weight Loss Doctor Explains

Understanding GLP-1 Agonists

Oprah and Yale Researcher Break Down How Weight Loss Drugs Affect the Brain

How do GLP-1 Agonists Work? (EASY Pharmacology)

Can Ozempic and Mounjaro Fix Thyroid Issues? The Anti-Inflammatory Power of GLP-1 Agonists!

Ozempic For Weight Loss: 6 Experts Share The Scary Truth Behind This "Miracle Drug"

7 Things You Must NEVER Do on Ozempic or Wegovy (Or It STOPS Working)

